Latest Breaking News On - Statistically significant reductions compared - Page 1 : comparemela.com

IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer s Agitation - Interim Data: Study Achieves Primary End Point Demonstrating.

United statesRam mukundaJanet vasquezRosalyn christianPharma incDrug administrationExchange commissionAnnounces positive interim resultsStatistically significant reductions comparedAgitation associatedDementia dueCohen mansfield agitation inventorySpecified interim resultsIllustrative brexpiprazole phaseArtificial intelligenceLooking statements